MAPT and neurodegenerative disease: Dysregulated PP2A activity — resulting from altered catalytic activity, subunit expression, methylation, and/or phosphorylation (62) — has been implicated in tau hyperphosphorylation (63) and amyloidogenesis (64), both of which are central pathological processes in neurodegenerative diseases (13, 65).